← All diseases Heart and blood vessels

Cardiac amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (41)Meta-analysis (6)Treatment guideline (1)Phase 3 study (19)Systematic review (12)Randomized Controlled Trial (3)Clinical trial (374)Review article (176)Early study (phase 1 or 2) (7)Case report (199)Laboratory or animal study (2)Commentary or Editorial (87) Studies currently recruiting participants only (37)

Filter

Publications and studies (1417)

• Commentary or editorialiAn expert's opinion or commentary, not new research. Amyloid-β and the Risk of Heart Failure: Cause or Only Association? (2023/01/01) ♡
• Left ventricular myocardial work index and short-term prognosis in patients with light-chain cardiac amyloidosis: a retrospective cohort study. (2023/01/01) ♡
• Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy. (2023/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Systemic immunoglobulin light chain (AL) amyloidosis initially presenting as hematochezia: a case report. (2023/01/01) ♡
• Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement. (2023/01/01) ♡
• Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis. (2023/01/01) ♡
• CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis. (2023/01/01) ♡
• Assessment of Interobserver Agreement in the Interpretation of (99m)Tc-PYP SPECT Imaging of Cardiac Amyloidosis. (2023/01/01) ♡
• Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. (2023/01/01) ♡
• Serial electrocardiographic and echocardiographic assessments of cardiac amyloidosis presenting with myocardial ischemia. (2023/01/01) ♡
• Registry of nuclear medicine procedures in cardiology in Poland in 2019-2021. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies. (2023/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Validation of Different Diagnostic Modalities in the Detection of Cardiac Amyloidosis Among Patients With "Red Flags" (2023-12-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Edge-to-edge Mitral Valve Repair in ATTR-CM (2023-12-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies (2023-11-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis Registry of University Hospital Leipzig (2023-11-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Aortic Stenosis and Cardiac Amyloidosis (2023-11-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy (2023-11-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population (2023-10-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study) (2023-10-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy (2023-09-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis (2023-09-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis (2023-09-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study) (2023-09-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis Registry Study (2023-09-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR (2023-08-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mitochondrial Function in Transthyretin Amyloidosis (2023-08-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Heart Failure: Don't Forget the Role of Amyloidosis (2023-08-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment (2023-07-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction (2023-06-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation (2023-06-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis. (2023-04-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers (2023-04-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Identification of Clinically Significant Markers of ATTRv in Pre-symptomatic Mutation Carriers. (2023-03-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Wild Type ATTR (2023-03-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis (2023-03-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults (2023-02-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) (2023-02-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics (2023-02-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis. (2023-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis. (2023-01-27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Proteolysis in Amyloidosis. (2022/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Cardiac progression of systemic light chain amyloidosis]. (2022/12/31) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Tafamidis Beyond the ATTR-ACT Trial: The Winner Takes It All. (2022/12/30) ♡
• Role of Diphosphonates Bone Scintigraphy in Correlation with Biomarkers for a Personalized Approach to ATTR Cardiac Amyloidosis in North-Eastern Romania. (2022/12/28) ♡
• CMR-based right ventricular strain analysis in cardiac amyloidosis and its potential as a supportive diagnostic feature. (2022/12/28) ♡
• Physical Performance in Black and Hispanic Outpatients With Heart Failure: The SCAN-MP Study. (2022/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early and aggressive presentation of wild-type transthyretin amyloid cardiomyopathy: A case report. (2022/12/26) ♡
• Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: Correlations with cardiac MRI. (2022/12/26) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.